$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
能倍乐功效和作用
2025-10-19 11:44:20
Check Details
能倍乐在哪儿能买到?
2025-10-19 11:44:20
Check Details
罗氟司特效果怎么样?
2025-10-19 11:44:20
Check Details
那些年,我们了解过的明星药之罗氟司特
2025-10-19 11:44:20
Check Details
治疗慢性阻塞性肺疾病新药-罗氟司特
2025-10-19 11:44:20
Check Details
能倍乐被证实可改善哮喘患者的呼吸症状
2025-10-19 11:44:20
Check Details
慢阻肺患者的福音!能倍乐已在华上市!
2025-10-19 11:44:20
Check Details
罗氟司特治疗支气管哮喘的效果数据
2025-10-19 11:44:20
Check Details
慢性阻塞性肺疾病新星-罗氟司特
2025-10-19 11:44:20
Check Details
思力华已在我国获批上市,慢阻肺患者迎福音
2025-10-19 11:44:20
Check Details
思力华安全性和疗效获最大型慢阻肺临床试验证实
2025-10-19 11:44:20
Check Details
罗氟司特用于治疗慢性阻塞性肺疾病的效果怎么样?
2025-10-19 11:44:20
Check Details
1
2
...
3434
3435
3436
3437
3438
3439
3440
...
10230
10231
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Capmatinib (Tabrecta): Oral Targeted Therapy for MET Exon 14 Skipping-Mutated NSCLC
2
Amivantamab Plus Lazertinib: A Chemotherapy-Free First-Line Option in EGFR-Mutated NSCLC
3
Midostaurin (Rydapt): Dosing Essentials in FLT3-Mutated AML and Systemic Mastocytosis
4
Lapatinib: An Oral Dual EGFR/HER2 TKI in HER2-Positive Breast Cancer
5
Filgotinib (Jyseleca) Overseas Guide: JAK1 Inhibitor for Rheumatoid Arthritis and Ulcerative Colitis
6
FDA Approves LISRAYA (brepocitinib): First Oral Targeted Therapy for Adults with Dermatomyositis
7
Elagolix for Endometriosis Pain: Indications and Usage Guidelines
8
Bosentan vs. Antihypertensives: What PAH Patients Need to Know
9
Letermovir: Proper Usage and Important Precautions
10
FDA Approves Daraxonrasib, Marking Milestone in Metastatic Pancreatic Cancer Treatment
11
Brensocatib for Non-Cystic Fibrosis Bronchiectasis: Patient Selection, ASPEN Data, and Safety Profile
12
Mirdametinib Mechanism and Clinical Guide: MEK Inhibitor for NF1 Plexiform Neurofibromas